No results for ‘’
Alfavision Overseas (India) Ltd
₹9.29
(1.42%)
Thu, 18 Jun 2026, 02:39 pm
Health Technology
Biotechnology
24.5KAlfavision Overseas (India) Enterprise Value (EV)
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 9.35 | 10.69 | 10.11 | 67.57 | 100 | 130.91 | 44.78 | 37.04 | 121.18 | 78.31 | 70.74 | 74.34 | 68.71 | 47.57 | 8.76 | 20.38 | 49.58 | 161.80 | 332.38 |
| Price to book ratio | 1.52 | 0.92 | 0.56 | 1.25 | 1.33 | 1.40 | 1.41 | 1.36 | 4.48 | 2.73 | 2.52 | 1.95 | 1.32 | 0.95 | 1.23 | 0.90 | 0.81 | 1.07 | 0.96 |
| Price to sales ratio | 3.78 | 1.97 | 0.68 | 1.28 | 2.31 | 1.59 | 0.38 | 0.25 | 0.67 | 0.65 | 0.62 | 0.16 | 0.09 | 0.05 | 0.07 | 0.23 | 1.10 | 14.30 | 21.22 |
| Price to cash flow ratio | 37.09 | 0 | 0 | 0 | 0 | 8.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 90.53 |
| Enterprise value | 7.84Cr | 5.54Cr | 5.09Cr | 9.39Cr | 11Cr | 10.72Cr | 12.62Cr | 12.72Cr | 36.09Cr | 22.57Cr | 24.94Cr | 41.52Cr | 41.62Cr | 60.17Cr | 70.28Cr | 183Cr | 159Cr | 169Cr | 165Cr |
| Enterprise value to EBITDA ratio | 10.58 | 11.20 | 21.40 | 0 | 0 | 0 | 228.81 | 116.09 | 164.80 | 88.42 | 41.46 | 21.40 | 17.27 | 17.95 | 17.51 | 37.08 | 69.62 | 176.20 | 1140 |
| Debt to equity ratio | 0 | 0.09 | 0.27 | 0.24 | 0.42 | 0.29 | 0.50 | 0.50 | 0.61 | 0.32 | 0.70 | 3.01 | 3.54 | 5.82 | 5.56 | 3.14 | 3 | 2.96 | 2.95 |
| Return on equity % | 0 | 8.55 | 5.70 | 1.89 | 1.32 | 1.09 | 3.22 | 3.75 | 3.78 | 3.56 | 3.64 | 2.70 | 1.94 | 2.01 | 15.16 | 7.26 | 1.56 | 0.65 | 0.29 |
Alfavision Overseas (India) Ltd Enterprise Value
The Alfavision Overseas (India) Ltd Enterprise Value is a key financial metric used by investors to evaluate Alfavision Overseas (India) Ltd's valuation, profitability, and overall financial performance. Tracking the Alfavision Overseas (India) Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Alfavision Overseas (India) Ltd (NSE: , BSE: 531156) is currently trading at ₹9.29, with a market capitalization of ₹28.88Cr. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Alfavision Overseas (India) Ltd Enterprise Value is essential for fundamental analysis.
Alfavision Overseas (India) Ltd Enterprise Value Current Value
The current Alfavision Overseas (India) Ltd Enterprise Value stands at 165Cr.
The Alfavision Overseas (India) Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Alfavision Overseas (India) Ltd Enterprise Value Historical Trend
The Alfavision Overseas (India) Ltd Enterprise Value has shown the following historical trend:
- 2024: 165Cr
- 2023: 169Cr
- 2022: 159Cr
- 2021: 183Cr
- 2020: 70.28Cr
The decline in Alfavision Overseas (India) Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Alfavision Overseas (India) Ltd Enterprise Value Indicates for Investors
The Alfavision Overseas (India) Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Alfavision Overseas (India) Ltd.
Alfavision Overseas (India) Ltd Enterprise Value Analysis Summary
The Alfavision Overseas (India) Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Alfavision Overseas (India) Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Alfavision Overseas (India) Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.